Travere Therapeutics to Report First Quarter 2026 Financial Results View Full Press Release Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Travere Therapeutics Reports First Quarter 2026 Financial Results